85 related articles for article (PubMed ID: 40574)
1. Cyclohexylphenoxy amidoximes and imidazolines with antidepressive and alpha-adrenergic activity.
Picciòla G; Carissimi M; Ravenna F; Gentili P; Carenini G
Arzneimittelforschung; 1979; 29(5):729-38. PubMed ID: 40574
[TBL] [Abstract][Full Text] [Related]
2. [Cyclohexylphenoxymorpholines with antidepressive activity].
Carissimi M; Picciòla G; Ravenna F; Gentili P; Carenini G
Farmaco Sci; 1980 Jun; 35(6):504-26. PubMed ID: 7192648
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological studies on ticlopidine, a new platelet aggregation inhibitor. Part II: General pharmacological properties.
Akashi A; Hashizume T; Tanaka M; Naka S; Hirohashi M; Kasai Y; Sakurai T; Watanabe K; Tsubokawa M; Kasahara A
Arzneimittelforschung; 1980; 30(3):415-9. PubMed ID: 7387751
[No Abstract] [Full Text] [Related]
4. Pharmacological evaluation of delta2, 1,2,4-triazolin-5-one [1,3(4-m-chlorophenyl-1-piperazinyl)-propyl]-3,4-diethyl-hydrochloride (Etoperidone), a new potential antidepressant drug.
Ramacci MT; Ghirardi O; Maccari F; Pacifici L; Sale P
Arzneimittelforschung; 1979; 29(2):294-307. PubMed ID: 582144
[No Abstract] [Full Text] [Related]
5. [Derivatives of 4-phenylcyclohexylethylamine with antidepressive activity].
de Meglio P; Ravenna F; Carenini G; Gentili P; Manzardo S; Tempra Gabbiati G; Riva M
Farmaco Sci; 1982 Dec; 37(12):836-58. PubMed ID: 6927300
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological studies on 5-(3-(4-piperidino-4-carbamoyl-piperidino)-propyl)-10,11-dihydro-5(H)-dibenz-(b,f)-azepine (carpipramine) dihydrochloride, a new psychotropic agent.
Nakanishi M; Tsumagari T; Okada T; Kasé Y
Arzneimittelforschung; 1968 Nov; 18(11):1435-41. PubMed ID: 5755909
[No Abstract] [Full Text] [Related]
7. Pharmacological properties of 2,3-dihydro-9H-isoxazolo[3,2-b]-quinazolin-9-one (W-2429. Part 2: General pharmacological investigation.
Sofia RD; Diamantis W; Gordon R; Edelson J; Ludwig BJ
Arzneimittelforschung; 1977; 27(4):782-9. PubMed ID: 405977
[No Abstract] [Full Text] [Related]
8. [Derivatives of 2-phenothiazin-2'-yl-cinchoninic acid with analgesic and anti-inflammatory activity].
Sparatore F; Savelli F; Cordella G
Farmaco Sci; 1980 Sep; 35(9):735-51. PubMed ID: 6969670
[TBL] [Abstract][Full Text] [Related]
9. 2-(Methyleneaminoxy)methylmorpholine derivatives. Synthesis and antidepressant activity.
Balsamo A; Lapucci A; Macchia M; Martinelli A; Nencetti S; Rossello A; Cristina T
Farmaco; 1994 Feb; 49(2):77-82. PubMed ID: 8003184
[TBL] [Abstract][Full Text] [Related]
10. Aromatic and benzylic hydroxyl substitution of imidazolines and phenethylamines: differences in activity at alpha-1 and alpha-2 adrenergic receptors.
Ruffolo RR; Waddell JE
J Pharmacol Exp Ther; 1983 Mar; 224(3):559-66. PubMed ID: 6131121
[No Abstract] [Full Text] [Related]
11. [Synthesis and pharmacologic study of derivatives of orciprenaline and salbutamol. II. Guanidine and amidoxime derivatives of salbutamol].
de Meglio P; Ravenna F; Gentili P; Manzardo S; Riva M
Farmaco Sci; 1983 Dec; 38(12):998-1012. PubMed ID: 6667742
[No Abstract] [Full Text] [Related]
12. Resolution and adrenergic activities of the optical isomers of 4-[1-(1-naphthyl)ethyl]-1H-imidazole.
Hong SS; Romstedt KJ; Feller DR; Hsu FL; George C; Cupps TL; Lyon RA; Miller DD
Chirality; 1992; 4(7):432-8. PubMed ID: 1361151
[TBL] [Abstract][Full Text] [Related]
13. N(alpha)-imidazolylalkyl and pyridylalkyl derivatives of histaprodifen: synthesis and in vitro evaluation of highly potent histamine H(1)-receptor agonists.
Menghin S; Pertz HH; Kramer K; Seifert R; Schunack W; Elz S
J Med Chem; 2003 Dec; 46(25):5458-70. PubMed ID: 14640554
[TBL] [Abstract][Full Text] [Related]
14. General pharmacological properties of 4-(p-chlorophenylthio)butanol (W-2719).
Diamantis W; Sofia RD; Gordon R; Ludwig BJ
Arzneimittelforschung; 1979; 29(7):998-1004. PubMed ID: 315234
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and pharmacological activity of befuraline (N-benzo[b]furan-2-ylcarbonyl-N'-benzylpiperazine), a new antidepressant compound.
Boksay IJ; Popendiker K; Weber RO; Söder A
Arzneimittelforschung; 1979; 29(2):193-204. PubMed ID: 582130
[TBL] [Abstract][Full Text] [Related]
16. [2-(2-Thienyl)morpholines with CNS activity].
Carissimi M; Picciòla G; Ravenna F; Carenini G; Gentili P
Farmaco Sci; 1980 Oct; 35(10):812-25. PubMed ID: 6969667
[TBL] [Abstract][Full Text] [Related]
17. General pharmacology of the new antimuscarinic compound vamicamide.
Yamamoto T; Honbo T; Tokoro K; Kojimoto Y; Kodama R; Ohtsuka M; Shimomura K
Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
[TBL] [Abstract][Full Text] [Related]
18. General pharmacological properties of the new vasodilator flosequinan.
Ikezono K; Fujita S; Umezato M; Hosoki E; Toba Y; Kusunoki A; Shintani S
Arzneimittelforschung; 1992 Oct; 42(10):1200-11. PubMed ID: 1472141
[TBL] [Abstract][Full Text] [Related]
19. General pharmacology of oxepinac.
Kojima H; Hashizume T; Chiba T; Tanaka M; Kasai Y; Kasahara A
Arzneimittelforschung; 1978; 28(3):439-45. PubMed ID: 580753
[No Abstract] [Full Text] [Related]
20. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human).
Andoh K; Kimura T; Saeki I; Tabata R; Yamazaki S; Eguchi I; Hanazuka M; Horii D; Munt PL; Davis AS
Arzneimittelforschung; 1994 Jun; 44(6):715-26. PubMed ID: 8053970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
